Previous studies have suggested that miR-210-3p is involved in endometriotic cell proliferation and participates in the DNA damage response and cell cycle checkpoint in cancer cells via targeting AIFM3 and FGFRL1 (refs. 28,48), but the specific molecular mechanisms have not been determined. The gene discussed is FGFRL1; the disease is cancer.